Ion Biotechnology
Ion Biotechnology (USA), Inc. was incorporated in Texas in 2017. The company is applying metal ion technology as a potential cancer therapeutic. We are working with several of the world’s leading medicinal inorganic chemists to mature the technology in preparation for preclinical development.
Dennis Stone, CEO and Director 
Holt Smith, General Counsel and Director 
Alan Bailey, CFO and Director 
Dr. Debbie Crans, Chemistry and Biochemistry Advisor 
Dr. Maria Contel, Chemistry Advisor 
Dr. Michael Weickert, Business Advisor
Ion Biotechnology 